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Abstract
Most clinical MRSA (methicillin-resistant S. aureus) isolates exhibit low-level β-lactam resis-
tance (oxacillin MIC 2–4 μg/ml) due to the acquisition of a novel penicillin binding protein
(PBP2A), encoded by mecA. However, strains can evolve high-level resistance (oxacillin
MIC�256 μg/ml) by an unknown mechanism. Here we have developed a robust system to
explore the basis of the evolution of high-level resistance by inserting mecA into the chromo-
some of the methicillin-sensitive S. aureus SH1000. Low-level mecA-dependent oxacillin
resistance was associated with increased expression of anaerobic respiratory and fermen-
tative genes. High-level resistant derivatives had acquired mutations in either rpoB (RNA
polymerase subunit β) or rpoC (RNA polymerase subunit β’) and these mutations were
shown to be responsible for the observed resistance phenotype. Analysis of rpoB and rpoC
mutants revealed decreased growth rates in the absence of antibiotic, and alterations to,
transcription elongation. The rpoB and rpoC mutations resulted in decreased expression to
parental levels, of anaerobic respiratory and fermentative genes and specific upregulation
of 11 genes including mecA. There was however no direct correlation between resistance
and the amount of PBP2A. A mutational analysis of the differentially expressed genes
revealed that a member of the S. aureus Type VII secretion system is required for high level
resistance. Interestingly, the genomes of two of the high level resistant evolved strains also
contained missense mutations in this same locus. Finally, the set of genetically matched
strains revealed that high level antibiotic resistance does not incur a significant fitness cost
during pathogenesis. Our analysis demonstrates the complex interplay between antibiotic
resistance mechanisms and core cell physiology, providing new insight into how such impor-
tant resistance properties evolve.
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Author summary
Methicillin resistant Staphylococcus aureus (MRSA) places a great burden on human health-
care systems. Resistance is mediated by the acquisition of a non-native penicillin-binding pro-
tein 2A (PBP2A), encoded by mecA. MRSA strains are resistant to virtually all β-lactam
antibiotics, and can shift from being low- to high-level resistant. Prior studies have revealed
the involvement of components of the core genome in increased resistance, but the underlying
mechanism is still unknown. In this study, we have found that increased resistance is associ-
ated with mutations in either rpoB (RNA polymerase subunit β) or rpoC (RNA polymerase
subunit β’) resulting in slower growth and elevated levels of PBP2A. Furthermore, transcript
profiling revealed that insertion of mecA triggered metabolic imbalance by altering anaerobic
and fermentative gene expression, accompanied by low-level resistance whereas, acquisition
of rpoB and rpoC mutations reversed gene expression to wild-type level and enabled cells to
become highly-resistant. The mutations also affected RNA polymerase activity. A set of
matched strains revealed that changes in antibiotic resistance levels do not have a significant
cost in terms of pathogenic potential. Our study reveals a novel effect of mecA acquisition on
central metabolism and sheds light on potential pathways essential for high-level resistance.
Introduction
Infections caused by Staphylococcus aureus as well as methicillin-resistant S. aureus (MRSA)
pose a significant and enduring threat to human healthcare [1,2]. β-Lactams act by binding to
the transpeptidase domain of PBPs [3], whose activity is required for the final stages of bacte-
rial cell wall peptidoglycan biosynthesis [4]. In staphylococci, oxacillin (methicillin) resistance
is most commonly mediated by a penicillin-insensitive penicillin-binding protein (PBP2A)
encoded by mecA which has low affinity for β-lactams and maintains cell wall biosynthesis in
the presence of β-lactams, with the help of the native bifunctional penicillin-binding protein
(PBP) PBP2, for its transglycosylase activity [5].
Nucleotide sequence determination of the early MRSA isolate, N315 [6], identified a novel
mobile genetic element, staphylococcal cassette chromosome mec (SCCmec) which carries the
mec gene complex, regulatory components, surrounding ORFs and insertion sequences [7,8].
In all cases, SCCmec integrates into the S. aureus genome near the origin of replication at the
3’ end of the orfX gene [9,10]. SCCmec also carries a cassette chromosome recombinase (ccr)
gene complex ensuring its mobility [11]. Currently, SCCmec elements are classified into types
I to XI on the basis of considerable structural variation in ccr and mec gene complexes [12].
To be resistant to methicillin, an MRSA strain must carry a functional copy of mecA, how-
ever, variations in temperature, osmolarity and pH alter the level of resistance conferred
[13,14]. Moreover, recent biochemical studies highlighted the importance of proper maturation
of PBP2A to exhibit broad β-lactam resistance [15]. Even though mecA is essential for resis-
tance, the level of resistance exhibited by clinical MRSA isolates varies greatly and this variation
cannot be simply due to the differences in the activity of regulatory genes/proteins (mecR1/
mecI) [16] as not all MRSA strains carry an intact mec regulatory system [17,18]. In addition,
isolates expressing low-level resistance (oxacillin MIC<2 μg/ml) exhibit heterogeneous expres-
sion of methicillin resistance, meaning that the majority of the bacterial population is sensitive
to low concentrations of antibiotic; however, a small proportion of cells exhibit high-level resis-
tance (>50 μg/ml) [14,16,19,20]. The frequency at which the highly resistant subpopulation
arises is about 10−4, which is reproducible and strain-specific [19]. Importantly, heterogeneously
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resistant strains are capable of expressing high-level resistance upon exposure to elevated con-
centrations of β-lactam antibiotics or under specific growth conditions [13,14]. The phenotypic
expression of high-level resistance is known as homogeneous resistance [14]. The transition
from low- to high-level resistance has been shown to involve mutational events or genetic rear-
rangements to accommodate the resistance pathway. Conversion from low- to high-level resis-
tance is complex, with mutations reported in genes associated with the stringent stress response
(relA, relQ), fem (factors essential for methicillin resistance), auxiliary factors (aux), transcrip-
tion (rpoB, rpoC), and c-di-AMP phosphodiesterase (gdpP); suggesting a network of processes
are required for resistance [16,20–24]. However, the mechanism underpinning the conversion
of low-level resistance into stable high-level resistance is ill-defined. Several studies to under-
stand the molecular basis of methicillin resistance have been carried out, but all have either
introduced multi-copy plasmid-borne mecA into a methicillin-sensitive isolate or used clinical
MRSA isolates with different genetic backgrounds exposed to β-lactam antibiotics [16,20,22].
Here, we have used the well-characterised strain S. aureus SH1000 carrying a chromosomal
copy of mecA to explore the mechanisms underpinning the acquisition of high-level methicil-
lin resistance. This provides a new model system to examine the complexity of high-level resis-
tance to β-lactam antibiotics.
Results
Construction and characterisation of highly oxacillin resistant derivatives
of SH1000
Naturally occurring clinical MRSA isolates carry a single copy of mecA within the SCCmec cas-
sette [7]. Therefore, we introduced mecA into the chromosome of SH1000 to better under-
stand the mechanisms required to permit high-level resistance to methicillin. The pMUTIN4
[25] based insertion suicide plasmid pGM068 [26] was used to integrate mecA under its native
promoter (pmecA) downstream of the lysA gene creating pVP01-pmecA. This plasmid con-
tains a truncated 3´ region of a lysA gene encoding the terminal enzyme of the lysine biosyn-
thesis pathway. Upon transformation of pVP01-pmecA into S. aureus, homologous
recombination occurs creating an insertional duplication of the lysA region, conferring eryth-
romycin resistance without lysine auxotrophy (Fig 1A).
The resultant “Untrained” strain lysA::pmecA (SJF4996) exhibited low-level oxacillin resis-
tance (MIC 2 μg/ml) compared to the parental SH1000 (MIC 0.12 μg/ml) (Fig 1B). This level
of resistance is similar to most clinical isolates of MRSA with heterogeneous resistance [27,28].
Highly oxacillin-resistant derivatives of lysA::pmecA (SJF4996) were subsequently isolated
using gradient BHI media supplemented with 5 and 20 μg/ml methicillin (Fig 1C and 1D).
This approach allowed selection of “Trained” mutants exhibiting oxacillin resistance levels
from <2 to�256 μg/ml MIC (S1 Table). The mecA gene was then cured from a highly resis-
tant derivative (SJF5003) by replacing lysA::pmecA with lysA::kan by phage transduction to
give strain SJF5010 with an oxacillin MIC of 0.5 μg/ml. Subsequent reintroduction, by trans-
duction, of mecA into lysA::kan (SJF5010) resulted in lysA::pmecA+ (SJF5011), with concomi-
tant high-level oxacillin resistance (MIC�256 μg/ml). Thus, mecA alone cannot impart high-
level resistance implying that chromosomal mutation(s) are also necessary.
Conversion from low- to high-level oxacillin resistance is promoted by
mutations in either rpoB or rpoC
Whole genome sequencing was performed on the parental strain (SH1000), lysA::pmecA
(SJF4996) and 14 highly oxacillin-resistant derivatives (S2 Table). Apart from the desired
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genetic manipulation, no other mutations were observed in SH1000 and lysA::pmecA
(SJF4996). The highly resistant strains harboured point mutations in either rpoB
(SAOUHSC_00524; DNA-directed RNA polymerase subunit β) or rpoC (SAOUHSC_00525;
DNA-directed RNA polymerase subunit β’) genes (S2 Table). The positions of the nonsynon-
ymous mutations that were identified in rpoB and rpoC are depicted on physical maps with
corresponding gene regions (Fig 2A).
In addition to rpo, some resistant strains had acquired other mutations. Strains lysA::pmecA
(SJF5002) and lysA::pmecA (SJF5006) had amino acid substitutions in the SAOUHSC_00269
and SAOUHSC_00270, which likely code for components of a Type VII secretion system ([29];
S2 Table). Four out of seven highly resistant strains had a base deletion that resulted in a
frameshift in the SAOUHSC_00591 gene encoding another hypothetical protein (S2 Table).
Unlike the rpoB/C mutations these mutations were not present in all the highly resistant
strains.
For two strains, lysA::pmecA (SJF5006) and lysA::pmecA rpoB-H929Q (SJF5003), a 12-bp
insertion (genome position 2134372) was present compared to NCTC8325 (S2 Table). This
insertion maps to SAOUHSC_02031 (rsbU), coding for the SigB regulatory protein RsbU. S.
Fig 1. Construction of a chromosomal pmecA fusion in S. aureus SH1000. A) Schematic overview of genomic region of lysA in SH1000 and post integration of
pVP01-pmecA resulting into lysA::pmecA (SJF4996). B) The lysA::pmecA (SJF4996) construct was produced by transduction from RN4220 lysA::pmecA (SJF4994). This led
to single copy mecA at the lysA locus expressed mecA under its native promoter. C) Subsequently, spontaneous oxacillin resistant mutants were selected using a gradient
plate containing either 0–5 or 0–20 μg/ml of methicillin. Strains with low-level resistance were further selected using an antibiotic gradient plate containing 0–20 μg/ml
methicillin to select high-level resistance. D) Etest strips revealed high-level oxacillin resistance was lost by removal of pmecA and restored via subsequent reintroduction
of pmecA at the lysA locus. Oxacillin MICs shown in brackets were measured using the Etest strip.
https://doi.org/10.1371/journal.ppat.1008672.g001
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aureus NCTC8325 carries a deletion in rsbU, which is repaired in SH1000 [30]. To investigate
the possible effects of SigB dysregulation, a phage lysate from lysA::pmecA (SJF4994) was trans-
duced into NCTC8325-4, a derivative of NCTC8325 with three prophages removed [31], creat-
ing S. aureus 8325–4 lysA::pmecA (SJF5035) with a defective rsbU gene. The oxacillin
sensitivity of S. aureus 8325–4 lysA::pmecA (SJF5035) (MIC 0.5 μg/ml) was similar to that of
the parental strain (MIC 0.12 μg/ml) (Fig 2B), suggesting that rsbU is unlikely to play an
important role in high level resistance.
Previous studies have reported that alterations in rpoB are involved in developing resistance
to methicillin, vancomycin and daptomycin [32]. Moreover, mutation in rpoC converts het-
erogeneously vancomycin-intermediate S. aureus (hVISA) into slow VISA which results in
increased oxacillin resistance [33,34]. All identified rpoB/C mutations associated with high-
level oxacillin resistance identified here resulted in amino acid substitutions towards the C-ter-
mini of RpoB and RpoC (Fig 2A). It has previously been reported that the locations of point
mutations in the rpoB gene determine the resistance to specific antibiotics. For example,
RpoB-H481Y is associated with high-level resistance to rifampicin as well as intermediate
resistance to vancomycin and RpoB-N967I and RpoB-R644H enhance methicillin, but not
rifampicin resistance [21,32,35]. The existence of rpoB/C mutations in clinical MRSA isolates
related to various lineages and their effect on developing β-lactam resistance was confirmed by
sequence alignment of strains, COL, USA300, MRSA252, Mu50 and JH9 (S2 Table). Interest-
ingly, USA300_FPR3757 has an rpoC mutation and yet it is quite sensitive to oxacillin. This
Fig 2. Identification of rpoB/C mutations and reconstitution of 8325–4 and Newman expressing single copy mecA. A) Schematic representation of the genomic
region of the rpoB/C operon, and downstream genes. Amino acid substitutions identified in resistant derivatives of lysA::pmecA (SJF4996) are indicated with a red
box representing highly resistant mutants with oxacillin MIC of�256 μg/ml and a grey box representing intermediate resistant mutants with oxacillin MIC of up to
16 μg/ml. B) Chromosomal integration of mecA at lysA locus in 8325–4 did not result in high-level oxacillin resistance. C) The introduction of lysA::pmecA and rpoB-
H929Q kan of SJF5046 into Newman resulted in the development of high-level resistance. Oxacillin susceptibility of Newman lysA::pmecA rpoB-H929Q kan (SJF5050)
and its parental strain Newman were compared using Etest.
https://doi.org/10.1371/journal.ppat.1008672.g002
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could be due to either additional mutation elsewhere in the chromosome or overexpression of
regulatory genes that could result in oxacillin susceptibility.
To test if the rpoB/C mutations lead to high-level β-lactam resistance, two highly resistant,
strains lysA::pmecA rpoB-H929Q (SJF5003) and lysA::pmecA rpoC-G740R (SJF5034) were
restored to wild-type rpoB and rpoC, respectively. Bacteriophage mediated transduction of the
above strains with an AJ1008 [36] phage lysate resulted in the introduction of a kanamycin
resistance marker; genetically linked to the WT rpoB/C genes. The resulting strains lysA::
pmecA rpoB+ (SJF5044) and lysA::pmecA rpoC+ (SJF5045) were oxacillin sensitive, indicating
that rpoB or rpoC mutations are needed for high-level resistance (S1A Fig). A similar approach
was used for S. aureus COL, replacing native rpoB (A798V, S875L) with SH1000 rpoB. The
resultant strain COL rpoB+ (SJF5049), was highly sensitive to oxacillin (MIC 0.5 μg/ml; S1A
Fig). Collectively, these observations confirm that the presence of rpoB/C mutations is suffi-
cient to develop oxacillin resistance in mecA positive strains.
We next addressed whether the mecA/rpoB/C-dependent high-level oxacillin resistance is
strain specific. Newman [37] was used for complete reconstitution of the high-level resistance
phenotype. In order to introduce the H929Q mutation into the rpoB gene of S. aureus New-
man, a phage lysate from AJ1008 with kanA near rpoB/C [36] was transduced into lysA::pmecA
rpoB-H929Q (SJF5003) and resultant transductants were screened for both kanamycin- and
oxacillin-resistance. This resulted in strain lysA::pmecA rpoB-H929Q kan (SJF5046). A phage
lysate from SJF5046 was used to transduce the rpoB-H929Q mutation into Newman. Subse-
quently, pmecA was introduced at the lysA locus resulting in Newman lysA::pmecA rpoB-
H929Q kan (SJF5050). This strain (SJF5050) was oxacillin resistant (MIC�256 μg/ml) com-
pared to Newman (MIC 0.12 μg/ml) (Fig 2C) and demonstrated that mecA/rpoB/C-dependent
high-level oxacillin resistance is not a strain-specific phenomenon.
Effects of rpoB and rpoC mutations on the activity of RNAP
The mutations in RNAP may alter enzyme properties and subsequent gene expression leading
to phenotypic conversion to high-level resistance. To test this, we purified RNAPs from wild-
type SH1000, lysA::pmecA rpoB-H929Q (SJF5003) and lysA::pmecA rpoC-G740R (SJF5034).
Transcription elongation can be the rate limiting, and, thus, the main regulatory step of gene
expression [38–41]. We therefore tested purified RNAPs for all activities during elongation
using artificially assembled elongation complexes [42–44]. The rates of nucleotide addition
and pyrophosphorolysis were not, or only slightly, affected by the mutations in rpoB-H929Q
and rpoC-G740R (S2 Fig), suggesting that catalysis of phosphodiester bond formation was not
altered. In contrast there were strong, but different, effects of rpoB-H929Q and rpoC-G740R
mutations on pausing at some of the positions of the template (S3 Fig). Transcription pausing
is the main way of regulation of transcription elongation, proving a potential link to altered
cell phenotype.
Transcription pausing can be caused by misincorporation of nucleotides [39,40]. However,
the rates of misincorporation were similar for all three RNA polymerases (S4 Fig). RNA cleav-
age is used to resolve misincorporation and backtracking events during transcription and the
apparent rate constant (kobs) for intrinsic cleavage of mis-incorporated nucleotides by the
rpoC-G740R mutant RNA polymerase was almost an order of magnitude faster than the native
RNAP (S5A Fig). This only applied to the intrinsic cleavage activity of rpoC-G740R mutant
RNAP, because Gre factor-assisted RNA cleavage in the same complex remained the same for
all three RNA polymerases (S5B Fig). Thus, rpoC-G740R mutation may positively affect
expression of the genes that are particularly affected by backtracking or contain misincorpora-
tion hotspots [40].
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Transcription initiation is also a heavily regulated step of transcription. We reconstructed
SH1000, lysA::pmecA rpoB-H929Q (SJF5003) and lysA::pmecA rpoC-G740R (SJF5034) RNAP
holoenzymes with housekeeping SigA and alternative sigma factor SigB. Their abilities to initi-
ate transcription in vitro (synthesis of trinucleotide) on pbp2, mecA and clfB promoters recog-
nised by SigA and the asp23 promoter recognised by SigB were compared. Unlike the above
experiments, initiation in vitro depends on specific activity of RNAPs. We, therefore, normal-
ised all the results to the activities of RNAPs on a strong orthologous A1 promoter of E. coli
bacteriophage T7 (rpoB-H929Q – 0.65%, rpoC-G740R – 0.64% of SH1000 RNAP activity; Fig
3A). The rpoB-H929Q mutant RNAP was impaired in initiating transcription from the SigA-
dependent promoters compared to the native and rpoC-G740R RNAP (Fig 3A). In contrast, all
the RNAPs behaved similarly at the SigB-dependent asp23 promoter (Fig 3A). The results
therefore suggest that differential gene expression in the lysA::pmecA rpoC-G740R strain
(SJF5034) is caused mainly by alterations in elongation of transcription, while the lysA::pmecA
rpoB-H929Q strain (SJF5003), by changes both of elongation and initiation of transcription.
We also tested whether the oxacillin intervention affect the transcription. RNAPs of SH1000,
lysA::pmecA rpoB-H929Q (SJF5003) and lysA::pmecA rpoC-G740R (SJF5034) had no effect on
transcription in the presence of high and low concentrations of oxacillin (S6 Fig).
Mutations in RNAP decrease emergence of Rifampicin resistance
The impact of rpoB/C mutations on RNAP was examined by mapping S. aureus rpoB/C muta-
tions onto the cryoEM structure of the E. coli RNAP elongation complex [45]. All S. aureus
mutations are in conserved residues with E. coli, except for one in RpoC (S852). The mutations
predominantly mapped either on the surface or towards the surface far from the catalytic cen-
ter (Fig 3B) [46]. Rifampicin (RMP) is an antibiotic that acts by binding within the RNAP β
subunit [47]. None of the identified mutations were located in the regions of binding of RMP
[36,47], which coincided with rifampicin sensitivity of the strains (Fig 3C; S2 Table). RMP
resistance is easily acquired (frequency of ~10−8) via point mutations within rpoB [48,49], but
these also may confer a great fitness cost [50]. We hypothesized that as MRSA strains already
carry mutations in rpoB or rpoC, they may not be able to develop supplementary RMP resis-
tance. As expected, resistant mutants occurred with frequencies of around 10−8 in SH1000 and
lysA::pmecA (SJF4996) (S5 Table). Conversely, lysA::pmecA rpoC-G740R (SJF5034) had a resis-
tance frequency of around 10−10 and for strains having the rpoB-G1139D and rpoB-Q643P
mutations RMP resistance was not detected (frequency <5×10−11; S5 Table). This suggests the
potential of RMP and its derivatives to treat infections caused by high level MRSA strains with
considerably lower risk of developing RMP resistance.
Mutations in rpoB and rpoC contribute to slower growth rates and
increased PBP2A production
In the absence of antibiotic, lysA::pmecA (SJF4996) exhibited a growth rate similar to that of
SH1000 (doubling times ~36 and ~35 min, respectively; Fig 4A). However, lysA::pmecA rpoB-
H929Q (SJF5003), lysA::pmecA rpoC-G740R (SJF5034) and lysA::kan rpoB-H929Q (SJF5010),
exhibited slower growth rates (doubling times ~48, ~55 and ~49 min, respectively) and similar
to COL (doubling time ~48 min). In the presence of 20 μg/ml oxacillin, the growth rate of
lysA::pmecA rpoB-H929Q (SJF5003), lysA::pmecA rpoC-G740R (SJF5034) and COL was unaf-
fected (Fig 4A). These observations suggest that the growth of highly resistant rpoB/C mutants
remains stable in the presence of oxacillin, similar to the clinical isolate COL. As lysA::kan
rpoB-H929Q (SJF5010) is oxacillin sensitive, slow growth cannot account for increased
resistance.
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In order to determine whether there was any correlation between oxacillin resistance and
the level of PBP2A, we compared the single copy chromosomal pmecA (lysA::pmecA) to strains
expressing plasmid-borne mecA (pRB474-pmecA) under the control of its native promoter (S7
Fig; S2 and S4 Tables). Plasmid-borne mecA strains were evolved similarly to our single copy
Fig 3. Location of rpoB/C mutations and the impact on transcription initiation. A) (i) Abortive products produced on the T7A1 promoter by S. aureus RNAPs over 10
min at 37˚C. (ii) Abortive initiation by SH1000, lysA::pmecA rpoB-H929Q (SJF5003) and lysA::pmecA rpoC-G740R (SJF5034) holoenzymes on the promoters of mecA,
pbp2, asp23 and clfB. Abortive products were normalised to abortive synthesis on T7A1 promoter. Error bars show ±SD from three replicates. B) The three-dimensional
structure of E. coli RNAP holoenzyme was used to map the rpoB and rpoC mutations [67]. The two subunits β (red) and β’ (blue) are shown as molecular surface. The
mutated residues of rpoB/C (S. aureus residue numbering) are highlighted with dots (Zoomed in section). �, residue not conserved in E. coli. C) S. aureus rpoB mutations
mapped on the structure of E. coli RpoB shows relative location of the mutations to the rifampicin binding pocket regions l and ll [47], shown as orange and cyan sticks,
respectively. Figure generated from PDB 6CUX using PYMOL.
https://doi.org/10.1371/journal.ppat.1008672.g003
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Fig 4. Growth characteristics and PBP2A production of S. aureus strains. A) Growth of representative strains, lysA::pmecA rpoB-H929Q (SJF5003), lysA::kan
rpoB-H929Q (SJF5010), lysA::pmecA rpoC-G740R (SJF5034) were compared to the SH1000, COL and lysA::pmecA (SJF4996) in the absence (left) and presence
PLOS PATHOGENS Evolution of β-lactam resistance in MRSA
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strains (S7 Fig). Apart from the genetic manipulation itself, no other mutations were observed
in SH1000 and SH1000 pRB474-pmecA (SJF4981). Oxacillin resistant derivatives of SH1000
pRB474-pmecA (SJF4981) harboured mutations in the gdpP gene encoding c-di-AMP phos-
phodiesterase [24] and not rpoB/C. Disruption or deletion of gdpP was found to be associated
with high-level resistance (S8B Fig and S4 Table). Removal and subsequent reintroduction of
pRB474-pmecA regained susceptibility and resistance, respectively in strains gdpP-R318L
(SJF4993) and gdpP-R318L pRB474-pmecA+ (SJF4995). To test if gdpP or rpoB could lead to
high level resistance irrespective of mecA copy number, strains gdpP-R318L lysA::pmecA
(SJF4997) and lysA::kan rpoB-H929Q pRB474-pmecA (SJF5024) (S9 Fig) were constructed.
Interestingly, gdpP-R318L lysA::pmecA (SJF4997) developed only low-level resistance to oxa-
cillin (MIC 8 μg/ml; S9A Fig) and lysA::kan rpoB-H929Q pRB474-pmecA (SJF5024) was sensi-
tive (MIC 0.5 μg/ml; S9B Fig). This suggests there are two independent mechanisms leading to
high-level resistance, where the delivery route of mecA determines which pathway is utilized.
Elucidation of the mechanism underlying this phenomenon requires further study.
Using the single copy and plasmid-borne mecA strains with a range of resistance properties
the level of PBP2A in the cells was compared (Fig 4B). Strain pRB474-pmecA gdpP-R318L
(SJF4991) produced the highest levels of PBP2A and was highly resistant, compared to the rest
of the strains (Fig 4B). Highly resistant strains with chromosomal pmecA; lysA::pmecA rpoB-
H929Q (SJF5003) and lysA::pmecA rpoC-G740R (SJF5034) showed only two-fold increase in
the amounts of PBP2A compared to lysA::pmecA (SJF4996) (Fig 4B) and less PBP2A than plas-
mid-borne strains with lower resistance levels.
Comparative transcript profiling reveals the effect of resistance evolution
on gene expression
To determine how resistance to β-lactam antibiotic evolves, the effect of mecA on global gene
expression was determined. Five S. aureus strains were used for transcript profiling: WT
(SH1000), lysA::pmecA (SJF4996), lysA::pmecA rpoB-H929Q (SJF5003), lysA::kan rpoB-H929Q
(SJF5010) and lysA::pmecA rpoC-G740R (SJF5034) (S2 Table). Differentially expressed genes
(DEGs) were identified by pair-wise and group-wise comparisons. Genes with an adjusted p
value <0.05 and log2 fold-change�±1 were deemed to be statistically significant.
(i) Determination of altered gene expression in response to acquisition of
mecA and rpo mutations
Comparing lysA::pmecA (SJF4996) to SH1000 revealed 193 DEGs. In contrast, only 9 DEGs
were identified for the lysA::pmecA rpoB-H929Q (SJF5003) compared to SH1000 (Fig 5A),
suggesting that expression of 190 genes had reverted to WT levels (Fig 5A). A total of 120
genes were differentially expressed in lysA::pmecA rpoC-G740R (SJF5034) compared to
SH1000, meaning that 73 genes were back at WT levels. One hundred and twenty two DEGs
(right) of oxacillin. Following one hour of incubation, 0.5 μg/ml of oxacillin was added to SH1000 and lysA::pmecA (SJF4996) cultures, and 20 μg/ml of oxacillin
was added to COL, lysA::pmecA rpoB-H929Q (SJF5003) and lysA::pmecA rpoC-G740R (SJF5034) cultures. Bacterial cultures were prepared in triplicate and the
error bars represent standard deviation of the mean (±SEM). B) Whole cell lysates (~10 μg of protein) of strains expressing chromosomal pmecA (single-copy;
lysA::pmecA) and plasmid-borne pmecA (multi-copy; pRB474-pmecA) were used to determine the amounts of PBP2A (~76kDa) and were compared between
these two set of strains. Plasmid-borne pmecA carrying strains include, pRB474-pmecA (SJF4981), TI11 pRB474-pmecA (SJF5194), pRB474-pmecA gdpP-R318L
(SJF4991) and gdpP-R318L lysA::pmecA (SJF4997). Chromosomal pmecA expressing strains include, lysA::pmecA (SJF4996), TI2 lysA::pmecA (SJF4999), lysA::
pmecA rpoB-H929Q (SJF5003) and lysA::pmecA rpoC-G740R (SJF5034). Anti-YmdA antibodies were used as an endogenous control producing ~58 kDa band.
Relative levels of PBP2A were calculated using ImageLab (Bio-Rad) quantitation tool, selecting recombinant PBP2A as a point of reference. The results of relative
concentrations of PBP2A are the average of three independent repeats where error bars represent standard deviation of the mean (±SEM). Oxacillin MICs are
listed in brackets for all strains above the bars.
https://doi.org/10.1371/journal.ppat.1008672.g004
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were solely associated with the rpoB-H929Q mutation of lysA::kan rpoB-H929Q (SJF5010)
compared to SH1000 (Fig 5C). These data illustrate the profound transcriptional changes asso-
ciated with the presence of mecA and how many of these changes are reversed upon subse-
quent acquisition of rpoB or rpoC mutations in the highly resistant strains.
Group-wise comparison of lysA::pmecA (SJF4996), lysA::pmecA rpoB-H929Q (SJF5003)
and lysA::pmecA rpoC-G740R (SJF5034) to SH1000 revealed the presence of only three
common DEGs. These were lysA, mecA and nirR (Fig 5D). The presence of lysA and mecA
in this group was not surprising, as the lysA::pmecA (SJF4996) was created by inserting the
mecA gene at the 3’ region of the lysA gene. Upregulation of nirR (Nitrate reductase regula-
tor) was apparent in lysA::pmecA (SJF4996) whereas, in lysA::pmecA rpoB-H929Q
(SJF5003) and lysA::pmecA rpoC-G740R (SJF5035), it was downregulated, suggesting that
the presence of mecA alone induces the expression of nirR (Fig 5D). Only lysA was found to
be common upon addition of lysA::kan rpoB-H929Q (SJF5010) into group-wise comparison
relative to WT (Fig 5E).
Fig 5. Differential gene expression in SH1000 follows the acquisition of chromosomal mecA and the rpoB/C mutations. Two-set proportional Venn
diagram illustrating the total number of differentially expressed genes (DEGs) altered in A) lysA::pmecA (SJF4996) (grey) and lysA::pmecA rpoB-H929Q
(SJF5003) (red), B) lysA::pmecA (SJF4996) (grey) and lysA::pmecA rpoC-G740R (SJF5034) (blue) and C) lysA::pmecA (SJF4996) (grey) and lysA::kan rpoB-
H929Q (SJF5010) (green) compared to WT (white background). D) Three-set proportional Venn diagram displaying the shared DEGs among lysA::
pmecA (SJF4996) (grey), lysA::pmecA rpoB-H929Q (SJF5003) (red) and lysA::pmecA rpoC-G740R (SJF5034) (blue) compared to WT (white background).
3 common DEGs (mecA, lysA, nirR) are marked by a circle showing reduced expression. E) The lysA gene (marked by a circle) was shared among four
strains based on comparisons from c) and d) compared to WT (white background). The expression of lysA was reduced in all four strains compared WT,
marked by a downward arrow.
https://doi.org/10.1371/journal.ppat.1008672.g005
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Hence, the rpoB/C mutations, particularly rpoB-H929Q, appear to dampen the perturba-
tions in gene expression caused by acquisition of mecA, whilst permitting enhanced mecA
expression, suggesting that ‘normalising’ global gene expression is a requirement for the devel-
opment of mecA-dependent high-level β-lactam resistance.
(ii) Differentially expressed genes associated with high-level resistance
Strains lysA::pmecA rpoB-H929Q (SJF5003) and lysA::pmecA rpoC-G740R (SJF5034) had
121 common DEGs compared to lysA::pmecA (SJF4996) (Fig 6A and S6 Table). Strains
lysA::pmecA rpoC-G740R (SJF5034) and lysA::kan rpoB-H929Q (SJF5010) had 35 common
DEGs relative to lysA::pmecA (SJF4996) (Fig 6B). Two pair-wise comparisons of lysA::
pmecA rpoB-H929Q (SJF5003) and lysA::kan rpoB-H929Q (SJF5010) strains against lysA::
pmecA (SJF4996) were combined to determine the transcriptional changes resulting from
the rpoB-H929Q mutation alone, revealing 28 common DEGs (Fig 6C). Finally, strains
lysA::pmecA rpoB-H929Q (SJF5003), lysA::kan rpoB-H929Q (SJF5010) and lysA::pmecA
rpoC-G740R (SJF5034); were compared to lysA::pmecA (SJF4996) yielding, 26 DEGs com-
mon to all three rpo strains. Notably, 22 DEGs were up-regulated in the lysA::pmecA
(SJF4996) strain whereas, the same 22 genes were down-regulated in the three rpo strains
(Fig 6D(i) and 6(ii)).
Functional categorisation of the 121 DEGs (95 specifically associated with high-level resis-
tance in response to the acquisition of rpoB-H929Q and rpoC-G740R plus 26 with altered
Fig 6. Identification and functional characterisation of overlapping genes and their differential expression in derived strains with a range of resistance properties.
Two-set proportional Venn diagrams displaying the total number of DEGs (listed in brackets), common (intersection) and unique DEGs altered in A) lysA::pmecA rpoB-
H929Q (SJF5003) (red) and lysA::pmecA rpoC-G740R (SJF5034) (blue), B) lysA::pmecA rpoC-G740R (SJF5034) (blue) and lysA::kan rpoB-H929Q (SJF5010) (green) and
C) lysA::pmecA rpoB-H929Q (SJF5003) (red) and lysA::kan rpoB-H929Q (SJF5010) compared to lysA::pmecA (SJF4996) (white background). D) Three-set proportional
Venn diagram comparing the three rpo strains relative to the lysA::pmecA (SJF4996) illustrated the 26 common DEGs among all three rpo strains and 95 overlapping
DEGs exclusively common between lysA::pmecA rpoB-H929Q (SJF5003) (red) and lysA::pmecA rpoC-G740R (SJF5034) (blue). Chord plots illustrating the differential
expression (DE) of 26 common genes (i) from lysA::pmecA (SJF4996) compared to WT. 24 out of 26 common genes (ii) were differentially expressed in the three rpo
strains compared to lysA::pmecA (SJF4996). mecA was not included as lysA::kan rpoB-H929Q (SJF5010) showed an obvious reduced mecA expression. Also, icaB was not
included because it was upregulated only lysA::pmecA rpoB-H929Q (SJF5003). The DE and functional categorisation of 95 common genes (iii) between lysA::pmecA rpoB-
H929Q (SJF5003) and lysA::pmecA rpoC-G740R (SJF5034) compared to lysA::pmecA (SJF4996) strain. Each segment on the left represents the average log2FoldChange of
individual genes from the three strains (SJF5003, SJF5010 and SJF5034) which connects to their functional categories on the right.
https://doi.org/10.1371/journal.ppat.1008672.g006
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expression in all three rpo strains) was achieved using the Clusters of Orthologous Groups
(COGs) database [51] (S6 Table).
Regulation of the 26 DEGs that were common to all three strains (SJF5003, SJF5010 and
SJF5034) was largely accounted for by one regulator, Rex (redox-sensing transcriptional
repressor; 16 genes) (S6 Table and Fig 7B). Rex responds to changes in the intracellular
NADH:NAD+ ratio to regulate genes associated with anaerobic metabolism [52]. In fact, 22 of
26 DEGs common to the three rpo strains (compared to the lysA::pmecA (SJF4996) strain)
were linked to anaerobic metabolism. The intracellular NADH:NAD+ ratio increases when
there is a ready supply of nutrients but aerobic respiration is impaired, usually due to oxygen
limitation. This change is sensed by Rex resulting in the de-repression of Rex-regulated genes
[52,53]. Hence genes associated with pyruvate- (ldh1, lctP, ald1, adhE, adh, pflA and pflB) and
anaerobic respiratory- metabolism (nirR, nirB, nirD, nasF, narG, narH, narT and narJ), as well
as genes coding for the oxygen-independent ribonucleotide reductase (nrdD and nrdG), were
more highly expressed in the lysA::pmecA (SJF4996) strain but were lowered to SH1000 levels
in the three rpo strains. Consistent with this interpretation, oxygen consumption rates (OCR)
for the lysA::pmecA (SJF4996) strain were significantly impaired compared to lysA::pmecA
rpoB-H929Q (SJF5003) and lysA::pmecA rpoC-G740R (SJF5034) strains (Fig 8). However, the
lysA::kan rpoB-H929Q (SJF5010) strain showed similar OCR to the lysA::pmecA (SJF4996)
strain, suggesting mecA- dependent and independent effects on cellular respiration. Anaerobic
metabolism results in the excretion of organic acids, such as lactate, which leads to culture
acidification [54,55]. Increased expression of the urease operon (ureABC) in lysA::pmecA
(SJF4996) but not in the three rpo strains, is likely a response to culture acidification. These
data suggest that expression of mecA may impair aerobic respiration resulting in increased
intracellular NADH:NAD+ ratios and de-repression of Rex-regulated ‘anaerobic’ genes, even
in the presence of oxygen.
Functional analysis of genes in high level resistance
The transcriptional profiling revealed several genes as candidate genes with potential roles in
endowing high level mecA-dependent resistance. These included genes involved in anaerobic
respiration and the associated regulatory gene rex. Also 11 genes were up-regulated in the rpo
mutant strains but not in lysA::pmecA (SJF4996) (S6 Table), suggesting a role in high level
resistance. Mutations were created by a mixture of unmarked deletions and use of available
transposon insertions. In order to accommodate the transposon resistance marker a new back-
ground strain was constructed (geh::pmecA lysA::tet rpoB-H929Q (SJF5323) (Oxacillin MIC
�256 μg/ml); S7 Table). The role of 14 genes (SAHOUHSC_00270, 00271, 00841, 00907,
00936, 01113, 01311, 02276, 02331, 02886, 01450, rex, adhE and pflB) in resistance was tested
by determination of the effect on oxacillin MIC of the respective mutations in geh::pmecA
lysA::tet rpoB-H929Q (SJF5323) (S7 Table). Only the unmarked deletion of SAOUHSC_00271
(lysA::pmecA rpoB-H929Q ΔSAOUHSC_00271 (SJF5344)) exhibited decreased resistance with
an oxacillin MIC of 32 μg/ml.
Effect of high-level resistance on S. aureus virulence
The set of strains with defined resistance properties, in isogenic backgrounds and with
sequenced genomes provided an ideal platform to establish any correlation between antibiotic
resistance and in vivo fitness (Fig 9). Groups of mice (n = 10) were infected with an individual
strain (1 x 107 CFU) of SH1000, lysA::pmecA (SJF4996), lysA::pmecA rpoB-H929Q (SJF5003),
lysA::kan rpoB-H929Q (SJF5010), lysA::pmecA rpoC-G740R (SJF5034), COL and COL rpoB+
(SJF5049). The presence of mecA led to increased weight loss and kidney CFU compared to
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SH1000 (Fig 9A–9C). The presence of the rpo mutations led to a decrease in weight loss com-
pared to SH1000 (Fig 9A) but no alteration to liver or kidney CFUs (Fig 9B and 9C). In the
COL background there was no alteration to pathogenesis associated with the rpoB allele (Fig
Fig 7. Functional classification and transcriptional regulation of common genes. A) COG (Clusters of Orthologous Groups) classification of 121
overlapping DEGs. Colours illustrate COG functional categories. C, Energy production and conversion; E, amino acid transport and metabolism; F,
nucleotide transport and metabolism; G, carbohydrate transport and metabolism; H, coenzyme transport and metabolism; I, lipid transport and metabolism;
P, inorganic ion transport and metabolism; Q, secondary metabolites biosynthesis, transport, and catabolism; M, cell wall/membrane/envelope biogenesis; O,
post-translational modification, protein turnover, and chaperones; T, signal transduction mechanisms; V, defence mechanisms; J, translation, ribosomal
structure and biogenesis; K, transcription; L, replication, recombination and repair; R and S are function prediction only or function unknown categories.
Total number of genes associated with each category are listed outside the bar. B) The transcriptional regulators were predicted for 24 out of 26 and 95
common DEGs identified in the three rpo strains compared to their parent (Fig 6D). C) Chromosomal region of the genes involved in nitrite and nitrate
reduction in S. aureus. A membrane bound nitrate reductase system (narGHJI) reduces nitrate to nitrite. Subsequently, nitrite is reduced to ammonia by
NADH-dependent nitrite reductase system (nirBD) [53]. NreABC has been identified as an oxygen sensing system which regulates the expression of nitrate
and nitrite reductase system as well as narK [68].
https://doi.org/10.1371/journal.ppat.1008672.g007
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9). Thus, high level resistance is not associated with a significant overall in vivo fitness cost, but
MecA alone may be advantageous during pathogenesis.
Discussion
Several studies have used model systems based on expression of mecA from multicopy plas-
mids in MSSA strains to plot the transition from low-level to high-level methicillin resistance
[16,20,56]. To match naturally occurring MRSA isolates we introduced a single copy mecA
into the chromosome of an MSSA strain (SH1000). This strain exhibited low-level resistance
and was characterized by enhanced expression of genes involved in anaerobic metabolism,
most of which were controlled by Rex (Fig 10). This implies that the redox balance of S. aureus
SH1000 carrying a chromosomal copy of mecA is perturbed with corresponding reduction in
aerobic respiration rate.
Selection for high-level resistant derivatives yielded strains with amino acid substitutions
either rpoB or rpoC that largely restored the parental (S. aureus SH1000) gene expression pro-
file, i.e. Rex-regulated ‘anaerobic’ genes were repressed, aerobic respiration rates increased and
by implication redox balance was restored (Fig 10). Mutations in rpoB/C have been identified
previously in highly resistant clinical isolates [21,22,57,58] but have not been well characterised
as genetic determinant(s) for developing high-level β-lactam resistance. Interestingly, 11
genes, including mecA, were up-regulated in the rpoB/C strains exhibiting high-level resistance
Fig 8. Oxygen consumption rates of S. aureus strains. Cellular respiration was measured for SH1000, lysA::pmecA
(SJF4996), lysA::pmecA rpoB-H929Q (SJF5003), lysA::kan rpoB-H929Q (SJF5010) and lysA::pmecA rpoC-G740R
(SJF5034) strains using Clark-type oxygen electrode. Data shown here reflect mean ±SEM of the three biological
replicates. The data were compared and analysed against WT and lysA::pmecA (SJF4996) using unpaired t-test. � p
<0.05.
https://doi.org/10.1371/journal.ppat.1008672.g008
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Fig 9. Virulence of S. aureus strains in a murine sepsis model. Mice were injected with 1 x 107 CFU per mouse with
SH1000, lysA::pmecA (SJF4996), lysA::pmecA rpoB-H929Q (SJF5003), lysA::kan rpoB-H929Q (SJF5010), lysA::pmecA
rpoC-G740R (SJF5034), COL, COL rpoB+ (SJF5049) and animals (n = 10 mice per group) were euthanised at 72 hpi. A)
Weight analysis. Colony forming units (CFUs) per organ B) Kidneys and C) Livers were recovered from animals infected
with strains listed above. Statistical significance determined by Mann-Whitney two-tailed test; ns, p>0.05; � p<0.05; ��p
<0.005.
https://doi.org/10.1371/journal.ppat.1008672.g009
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compared to lysA::pmecA (SJF4996). The ~2-fold increase in mecA expression was matched by
a ~2-fold increase in PBP2A protein, which could promote enhanced resistance. However,
there was no direct correlation between resistance and PBP2A levels. A functional analysis of
the other upregulated genes revealed SAHOUHSC_00271 as being required for high level resis-
tance. SAHOUHSC_00270 and 00271, code for two small membrane proteins of unknown
function and are found in the highly variable module 3 region of the Type VII secretion system
locus [59]. Interestingly, two high-level resistant strains (SJF5002 and SJF5006) had missense
mutations in SAHOUHSC_00270 and 00269 (S2 Table) [59]. This alludes to a function of the
Type VII secretion system in cell envelope function and hence the ability of PBP2A to impart
high level resistance (Fig 10).
A key remaining question is how the rpoB/C mutations result in increased expression of
mecA and the other 10 genes shown in Fig 10. A detailed analysis of the properties of rpoB-
H929Q (SJF5003) and rpoC-G740R (SJF5034) RNA polymerases revealed that both exhibited
different pausing properties. Pausing plays a major role in regulation of transcription, suggest-
ing that altered pausing behaviour at specific genes could alter their expression [40]. Our
defined system will permit the future elucidation of the complex interplay between subtle
changes to RNA polymerase and how this manifests as alterations in resistance properties.
Acquisition of an alternative component (PBP2A) to maintain the fundamental process of
peptidoglycan synthesis in the presence of oxacillin is unlikely to result in optimal perfor-
mance without further adaptations to integrate the new activity into the cell’s physiological
and regulatory networks. This is perhaps especially true in the case here, as peptidoglycan syn-
thesis is intimately connected to cell division and membrane function. On the basis of the
available evidence, acquisition and expression of mecA elicits low-level resistance and perturbs
cellular redox balance, resulting in depression of Rex-regulated genes, implying that mem-
brane function is compromised. The missense mutations in rpoB/C identified here represent a
Fig 10. Model of adaptations associated with the development of high-level β-lactam resistance. Strain lysA::pmecA (SJF4996) (left) expresses chromosomal mecA,
with PBP2A protein (red hour glass) incorporated into the cell envelope. This perturbs cell membrane (CM) function (?), resulting in decreased flux through the aerobic
electron transport chain (ETC). The resulting increased NADH:NAD+ ratio (indicated by font size) inhibits DNA-binding by the transcription factor Rex (green
hexagon) and the anaerobic respiratory and fermentative genes (anaerobic genes) are transcribed (red filled arrow) by the native RNA polymerase (RNAP). This results
in a low-level resistance phenotype. Evolved strains have missense mutations in the rpoB/C (RNAP�) that permit enhanced expression of 11 genes, including mecA and
two genes associated with the Type VII secretion system (SAHOUHSC_00270 and 00271). Incorporation of some of the gene products (e.g. SAHOUHSC_00270 and
00271; brown ellipses) into the cell membrane allows integration of PBP2A activity into ‘normal’ membrane function. This results in lower NADH:NAD+ ratios,
permitting Rex to repress expression of anaerobic genes (blue rectangle), the restoration of aerobic respiratory growth and high level β-lactam resistance.
https://doi.org/10.1371/journal.ppat.1008672.g010
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route to improved cell performance and high-level resistance. The enhanced transcriptional
pausing of these RNAP variants might enhance expression of genes, such as
SAHOUHSC_00271, to permit PBP2A activity to be integrated into a properly functioning cell
envelope, resulting in high-level resistance. Enhanced transcriptional pausing might impair
the formation of repressive complexes at those genes specifically up-regulated in the lysA::
pmecA rpoB-H929Q (SJF5003) and lysA::pmecA rpoC-G740R (SJF5034) strains.
Prior studies have noted that high level resistance is associated with a fitness burden in clin-
ical MRSA limiting the prevalence of these strains [60]. Interestingly, in vivo studies indicated
that the expression of mecA alone leads to slightly higher morbidity making the strain more
pathogenic (Fig 9). However, the acquisition of rpoB or rpoC mutations ameliorates the mecA
associated effects. Using our defined strains in both the SH1000 and COL backgrounds rpo
mutations, whilst leading to a reduced growth rate in vitro, did not result in a corresponding
attenuation in vivo. Thus, in the complex interaction with the host high level resistance may
not disadvantage the pathogen during infection. This complexity could be compounded by the
presence of β-lactamase and the range of mec regulatory system variants in the presence of
antibiotics.
In conclusion, this study has revealed a novel systemic effect of the acquisition of mecA on
cellular physiology and how compensatory mutations result in high level antibiotic resistance.
Our observations pave the way to begin to elucidate how such an important pathogen S. aureus
is able to develop high-level drug resistance and provides possible new avenues for therapeutic
development.
Materials and methods
Bacterial strains, plasmids and growth conditions
The bacterial strains and plasmids used in this study are described in S7 Table. Escherichia coli
strains were grown in Luria-Bertani (LB) liquid or solid medium supplemented with ampicil-
lin (100 μg/ml) at 37˚C. S. aureus strains were grown at 37˚C in Brain-Heart Infusion (BHI)
(Oxoid) solid or liquid medium supplemented when required with erythromycin (5 μg/ml)
plus lincomycin (25 μg/ml), chloramphenicol (10 μg/ml), tetracycline (5 μg/ml), kanamycin
(50 μg/ml), oxacillin (0–20 μg/ml) or methicillin (0–20 μg/ml).
Construction of strains and plasmids
For chromosomal integration of mecA, pMUTIN4 [25] based pGM068 [26] lysine insertion
plasmid was used to integrate mecA under its native promoter (pmecA) downstream of the
lysA gene. After construction by PCR and restriction/ligation methods, resulting
pVP01-pmecA plasmids were introduced into S. aureus RN4220 by electroporation enabling
the integration of plasmid into chromosome via homologous recombination. Oligonucleotides
are listed in S8 Table. The resultant erythromycin/lincomycin resistant constructs were then
transferred into other S. aureus strains as required byF11 transduction. For the complementa-
tion of rpoB-H929Q and rpoC-G740R mutations, a phage lysate from AJ1008 [36] with a kan
insertion next to rpoB/C was used to transduce resistance marker into mutant S. aureus strains.
Kanamycin resistant but oxacillin sensitive transductants were confirmed by PCR-based assays
for functional complementation. SJF5323 (geh::pmecA lysA::tet rpoB-H929Q) was constructed
by phage transduction of lysA::tet and geh::pmecA-kan into lysA::kan rpoB-H929Q (SJF5010).
S. aureus transposon mutants were obtained from the NARSA library (http://www.narsa.net).
The transposons from selected strains were transduced into geh::pmecA lysA::tet rpoB-H929Q
(SJF5323) (S7 Table) to allow their effects on oxacillin resistance to be determined.
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Genomic DNA was isolated using Qiagen DNeasy Blood and Tissue kit (Cat no. 69506) in
accordance with manufacturer’s instructions. Prior to DNA extraction 5–10 μl of 5 mg/ml
lysostaphin was added to resuspended S. aureus cells to facilitate lysis. Plasmid isolation was
carried out using GeneJET plasmid miniprep kit (Thermo Scientific) as per manufacturer’s
guidelines.
Isolation and whole genome sequencing of oxacillin resistant derivatives of
S. aureus SH1000
S. aureus SH1000 lysA::pmecA (single-copy) and SH1000 introduced with pRB474-pmecA
(multicopy) plasmid were tested for sensitivity to oxacillin. MIC values were determined using
antibiotic susceptibility tests using Etest M.I.C. Evaluator (Oxoid) strips. To obtain high-level
resistance to oxacillin, a strain obtained from both approaches (single-copy/multicopy mecA)
was grown on a methicillin gradient plate where, the bottom layer supplemented with 0-5/
20 μg/ml methicillin. This enabled the selection of single-copy/multicopy mecA derivatives
expressing range of oxacillin resistance (2 to�256 μg/ml). For the removal of single copy chro-
mosomal mecA, pGM068 (KanR) was phage transduced into oxacillin resistant derivative
swapping lysA::pmecA to lysA::kan. Curing the pRB474-pmecA plasmid from highly resistant
strain was achieved by subculturing the strain thirty times in the absence of chloramphenicol.
The genomes of representative strains listed in S7 Table were sequenced by MicrobesNG,
University of Birmingham. Genomic DNA was extracted by washing bead stocks with extrac-
tion buffer containing lysostaphin and RNase A followed by incubation at 37˚C for 25 min.
Proteinase K and RNase A were added and further incubated at 65˚C for 5 min. To purify
genomic DNA, equal volume of SPRI (Solid Phase Reversible Immobilisation) beads resus-
pended in EB buffer was used. DNA was quantified in triplicate using Quantit dsDNA HS
assay in a plate reader (Eppendorf). Genomic DNA libraries were prepared using Nextera XT
Library Prep Kit (Illumina) in accordance with manufacturer’s instructions. Library prepara-
tion and DNA quantification was carried out on a liquid handling system (Hamilton Microlab
STAR). Pooled libraries were quantified using Kapa Biosystems Library Quantification Kit for
Illumina on a Roche light cycler 96 qPCR machine. Libraries were sequenced on the Illumina
HiSeq using a 250 bp paired end protocol. Reads were trimmed using Trimmomatic 0.30 with
a sliding window cutoff of Q15 [61]. De novo assembly was performed on samples using
SPAdes version 3.7 [62]. For contigs annotation, Prokka 1.11 was used [63]. NCTC8325 whole
genome sequence was used as a reference for comparison. This pipeline for data analysis was
optimised and performed by MicrobesNG.
Detection of PBP2A by Western blot
S. aureus cells were grown to an OD600 ~1 in 100 ml BHI. Cells were collected by centrifuga-
tion for 10 min at 5,000 rcf in a pre-chilled centrifuge. The cell pellet was resuspended in PBS
and spun as before. This step was performed two more times. The pellet was resuspended in
500 μl PBS and added to pre-chilled lysing matrix tubes containing 0.1 mm acid-washed glass
beads (Sigma). Cells were broken using an MP Biomedicals FastPrep 24 Homogeniser (12x,
speed 6.5, 30 s). Samples were incubated on ice between each cycle. FastPrep beads were sepa-
rated by a brief spin for 30 s at 13,000 rpm. The supernatant was stored at -20˚C until needed.
Serum containing rabbit Anti-PBP2A antibody was incubated at room temperature with E.
coli whole cell lysate and then with S. aureus SH1000 whole cell lysate to remove cross-reactive
antibodies. The protein concentration of the lysates was measured using Bradford Assay (Bio-
Rad) and samples were normalised to equal amounts of protein, 10 μg of total protein was sep-
arated using 12% w/v SDS-PAGE. The primary antibody (1:5000 in 1x TBST plus 1% w/v skim
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milk) dilution of a rabbit anti-PBP2A polyclonal antibody was applied to membranes over-
night. A horseradish peroxidase (HRP) conjugated anti-rabbit IgG secondary antibody
(Sigma) (1:10,000 in 1xTBST plus 1% w/v skim milk) was incubated with the membrane for 1
hour. A chemiluminescence kit, Clarity ECL Western blotting substrates (Bio-Rad) was used
for visualisation of proteins. The membrane was scanned using ChemiDoc MP Systems (Bio-
Rad) for chemiluminescent detection.
Emergence of rifampicin resistance
Bacteria were grown aerobically at 37˚C in Bacto tryptic soy broth (soybean-casein digest
medium) (BD) supplemented with 5 μg/ml of oxacillin (Sigma) for MRSA strains until they
reached the late logarithmic phase of growth (OD625 ~1). The Rifampicin-resistant (RMP
R)
isolates were selected by plating 109−1011 cells per each plate supplemented with 5 or 100 μg/
ml of Rifampicin (RMP) (Sigma, cat. no. R3501) in addition to 5 μg/ml oxacillin for MRSA
strains. The final number of viable cells was determined by plating an appropriate dilution on
solid tryptic soy medium in the absence of RMP. Plates were incubated at 37˚C for 48 h and
the number of colonies on plates with different concentrations of RMP were counted. The
mutation frequencies were then calculated relative to the total number of viable cells plated.
RNA polymerase purification
Cell lysate was diluted with TGED (10 mM Tris-HCl pH 7.9, 5% v/v glycerol, 0.1 mM EDTA,
and 0.2 mM DTT) with 0.2 M NaCl to about 10 ml of buffer per 1 g of cells. Polyethylenimine
was added to 0.6% v/v and centrifuged at 8000 rpm for 10 min. The pellet was then washed
with TGED with 0.45 M NaCl. To elute RNAP, TGED with 1 M NaCl was added to the pellet
before centrifugation at 8000 rpm for 10 min and the supernatant collected. Ammonium sul-
phate was then added at 0.35 g/ml of supernatant. This was then centrifuged for 30 min at
15,000 rpm. The pellet was dissolved in TGED with 0.1 M NaCl and loaded on to a HiTrap
Heparin HP (GE Healthcare Life Sciences) equilibrated with TGED with no NaCl. A step elu-
tion was carried out using TGED with increasing concentrations of NaCl. Fractions containing
RNAP were loaded on to a RESOURCE Q ion exchange column (GE Healthcare Life Sciences)
pre-equilibrated with TGED with no NaCl. RNAP core was eluted in NaCl gradient (0.15–1 M
NaCl) in TGED. Fractions were pooled, concentrated, and supplied with 50% v/v glycerol for
storage. σ subunits and GreA factor were cloned from SH1000, expressed with 6xHis tags, and
purified by metal-affinity chromatography using standard methods.
In vitro transcription elongation assay
Oligonucleotides were from IDT. RNA was radiolabelled and complexes were assembled
exactly as described [42,64] using 0.3 μM RNA, 0.7 μM template DNA, and 7 μM non-template
DNA with 1 pmol RNAP per reaction in 10 μl of transcription buffer (20 mM Tris-HCl, pH
7.9, 40 mM KCl). Non-template DNA was biotinylated at the 3’ end, allowing for immobilisa-
tion on streptavidin beads. Reactions were started by addition of 10 mM MgCl2 with or with-
out NTPs (GE Healthcare) to concentrations shown in figure legends, or 50 μM
pyrophosphate (Sigma), or 5 μM GreA. Reactions were incubated at 37˚C for times indicated
in figures and stopped with an equal amount of formamide-containing buffer. Products were
resolved in denaturing (8M urea) polyacrylamide gels, visualised by phosphorimaging and
analysed using ImageQuant (GE Healthcare). All reactions were repeated at least three times.
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In vitro transcription initiation assay
One pmol of wild-type or mutant S. aureus RNAP core and 5 pmols of σA or σB (saturating
amount) and 0.2 pmols of a linear template containing sequence from -200 to +100 around the
transcription start site of pbp2, mecA and clfB, or ASP23 genes of SH1000 or a T7A1 promoter
[65,66] were mixed in 8 μl of initiation buffer (20 mM Tris acetate pH 7.9, 40 mM potassium
acetate, 0.5 mM DTT, 1 μg/ml Bovine Serum Albumin (BSA), 10 mM MgCl2). Transcription
was initiated by the addition of 2 μl of the mixture of (final concentrations): 100 μM dinucleo-
tide primer (IDT) corresponding to-1/+1 position of the promoter and 10 μM α-[32P] NTP
(20 Ci/mmol) (Hartmann Analytic) corresponding to +2 position. Reactions were stopped
after 10-min incubation at 37˚C by the addition of formamide-containing loading buffer. Tri-
nucleotides were separated from unincorporated radioactive NTP on 33% denaturing (8M
urea) polyacrylamide gels and revealed as above. Reactions were repeated at least three times.
Activities on S. aureus promoters were normalized to the activities on T7A1 promoter.
Total RNA extraction and RNA-seq
Extraction and purification of S. aureus total RNA was carried out using a Qiagen RNeasy Plus
Mini kit (Cat no. 74134). Fresh bacterial culture of OD600 ~0.05 was grown in to OD600 ~0.5. 8
ml of Qiagen RNAprotect Bacteria Reagent (Cat no. 76506) was added to 8 ml of culture in a
50 ml tube and incubated for 5 min at room temperature. Cells were recovered by centrifuga-
tion at 4000 rpm for 10 min at 4˚C. Pellets were stored at -70˚C. 200 μl of TE buffer (30 mM
Tris-HCl, 1 mM EDTA, pH 8.0) and 200 μl proteinase K solution was added to the RNApro-
tect Bacteria Reagent treated pellet and vortexed. Tubes were incubated for 1 hour at 37˚C in a
waterbath. The cell suspension was mixed by vortexing every 10 min for at least 10 s. Pellets
were resuspended in 700 μl of RLT buffer containing β-mercaptoethanol. Cells were then dis-
rupted using MP Biomedicals FastPrep 24 Homogeniser (3x, speed 6.5, 30 s). Cells were incu-
bated on ice for 5 min between each cycle. The cell lysates were centrifuged for 30 s at 13,000
rpm to separate lysing matrix. Supernatant was harvested in a gDNA eliminator column and
spun for 30 s at 10,000 rpm. Manufacturer’s protocol was followed from here onwards. RNA
concentration was measured using NanoDrop. RNA samples were stored at -4˚C for a month
or -70˚C for longer period.
RNA-Seq for transcriptome analysis was performed by Glasgow Polyomics, University of
Glasgow. Total RNA samples of three biological replicates for each strain were subject to QC
prior to library preparation followed by ribosomal depletion using TruSeq stranded total RNA
kits (Illumina). The generated raw data was compared to NCTC8325 reference sequence for
expression quantification and transcript annotation. Preliminary bioinformatics support for
data analysis was provided by Glasgow Polyomics which included expression quantification,
statistics and differential expression analysis.
Rate of respiration
Clark-type oxygen electrode (Rank Bros Ltd) was used to measure rate of respiration. The
apparatus contains an electrode operating at a polarising voltage of 0.6 V separated by a cham-
ber with an oxygen-permeable Teflon membrane. The reduction in the oxygen concentration
was measured at the cathode which creates a potential difference. The potential difference is
measured by LabTrax-4 and LabScribe2 software (World Precision Instruments). The temper-
ature of the chamber was maintained at 37˚C and stirred at a constant rate. Prior to the experi-
ment, the chamber was calibrated from 100% oxygen saturation to 0% oxygen by the addition
of sodium dithionate. 50 ml of BHI was inoculated with a single colony and incubated over-
night at 37˚C with 250 rpm shaking. Next morning, overnight culture was diluted to 1:50 in 50
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ml fresh BHI and incubated to produce log phase culture for 3 h at 37˚C with 250 rpm shaking.
The cultures were centrifuged at 3,380 rcf for 10 min at 4˚C and supernatant discarded. The
pellet was washed twice by resuspension in ice-cold 0.02 M PBS followed by centrifugation as
described above. The washed cell pellet was resuspended in 1 ml ice-cold 0.02 M PBS and kept
on ice until needed. Following electrode calibration, 1950 μl of 0.02 M PBS was added to the
electrode chamber and the system was left idle for 15 min to stabilise oxygen concentration
inside the chamber. 50 μl of sample was added to the chamber and allowed to stabilise for 5
min. The chamber was then sealed with the lid. After 5 min, 50 μl of 1 M glucose was injected
into the chamber through the lid to begin respiration. The oxygen consumption was recorded
and respiration rates were calculated as nmolO2/min.
Murine sepsis models
6–8 weeks old female BALB/c mice (Charles River Laboratories, UK) were housed in desig-
nated animal facilities using standard husbandry protocols. Bacteria for inoculum were grown
to stationary phase in BHI and washed 3 times in sterile endotoxin free PBS and finally resus-
pended in PBS containing 10% (w/v) Bovine Serum Albumin and stored at -80˚C until
required. Dilutions were made to the bacterial stocks prior to injection using sterile endotoxin
free PBS, with doses of 1 x 107 CFU per mouse (n = 10). Injections (100 μl) were made intrave-
nously in the tail vein. Viable bacteria in the inoculum were quantified by serial dilution and
plating onto BHI agar, and leaving overnight at 37˚C, before directly counting the CFU to
determine injected dose. Mice were monitored and euthanised at 72 hpi unless otherwise
stated or according to experimental design. Mouse organs (livers and kidneys) were individu-
ally homogenised in PBS using a Precellys 24 homogeniser. CFU per organ were determined
by plating 10 μl spots of serial dilutions of the homogenate onto BHI agar for bacterial number
enumeration and Statistical significance determined by Mann-Whitney two-tailed test; ns, p
>0.05; � p<0.05; ��p<0.005.
Ethics statement
Murine work was carried out according to UK law in the Animals (Scientific Procedures) Act
1986, under Project License P3BFD6DB9 (Staphylococcus aureus and other pathogens, patho-
genesis to therapy).
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S1 Table. List of S. aureus strains associated with single copy mecA (lysA::pmecA). �,
denotes trained strains with intermediate oxacillin resistance (TI); †, denotes trained strains
with high-level oxacillin resistance (TR); ‡, denotes TI strain trained further for high-level oxa-
cillin resistance (TIR).
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S2 Table. Identification of mutations and Antibiogram of MRSA and SH1000 derived oxa-
cillin resistant strains. �, Only DNA sequencing was performed for the rpoB and rpoC genes;
†, frameshift mutation; ‡, 11-bp insertion; a, representative strains used in this study; b, data
taken from [1]; S, Sensitive. OX, Oxacillin; FOX, Cefoxitin; PG, Penicillin G; RIF, Rifampicin.
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S3 Table. List of S. aureus strains associated with plasmid-borne mecA (pRB474 pmecA). �,
denotes trained strains with intermediate oxacillin resistance (TI); †, denotes trained strains
with high-level oxacillin resistance (TR); ‡, denotes TI strain trained further for high-level
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oxacillin resistance (TIR).
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S4 Table. Mutations identified by whole genome sequencing in SH1000 pRB474-pmecA
derivatives relative to NCTC8325.
(PDF)
S5 Table. Mutations frequencies for rifampicin resistance in S. aureus strains. Frequencies
of rifampicin-resistant colonies for strains carrying rpoBC mutations were determined from
plates spread with 109 to 1011 viable cells supplemented with 5 and 100 μg/ml rifampicin. Fre-
quency of RMPR mutants expressed as average (±SD) number of RMPR colonies from three
independent experiments. <5×10−11 corresponds to no colonies detected.
(PDF)
S6 Table. Functional classification and differential gene expression of shared gene pools of
mecA+ and mecA+ rpo strains. �, compared against WT; †, compared against lysA::pmecA
(SJF4996); 26 DEGs shared by all three rpo mutant strains are highlighted in blue, related to
Fig 6D. Clusters of orthologues groups of proteins (COGs) were retrieved from NCBI for 121
common DEGs associated with high-level resistance where, CELLULAR PROCESSES AND
SIGNALING includes, [M] Cell wall/membrane/envelope biogenesis; [O] Post-translational
modification, protein turnover, and chaperones; [T] Signal transduction mechanisms; [V]
Defence mechanisms; INFORMATION STORAGE AND PROCESSING includes [J] Transla-
tion, ribosomal structure and biogenesis; [K] Transcription; [L] Replication, recombination
and repair; METABOLISM includes [C] Energy production and conversion; [E] Amino acid
transport and metabolism; [F] Nucleotide transport and metabolism; [G] Carbohydrate trans-
port and metabolism; [H] Coenzyme transport and metabolism; [I] Lipid transport and
metabolism; [P] Inorganic ion transport and metabolism; [Q] Secondary metabolites biosyn-
thesis, transport, and catabolism; and POORLY CHARACTERIZED includes [R] General
function prediction only; [S] Function unknown.
(PDF)
S7 Table. List of strains and plasmids used in this study. �, denotes trained strains with inter-
mediate oxacillin resistance (TI); †, denotes trained strains with high-level oxacillin resistance
(TR); ‡, denotes TI strain trained further for high-level oxacillin resistance (TIR).
(PDF)
S8 Table. List of oligonucleotides used in this study.
(PDF)
S1 Fig. Oxacillin resistance and levels of PBP2A in rpoB/C complemented strains. A) Oxa-
cillin susceptibility for parental and genetically complemented strains (stated as above) were
compared using the Etest method. Oxacillin MICs are listed in brackets. B) The amounts of
PBP2A (~76kDa) was determined using whole cell lysates of lysA::pmecA rpoB-H929Q
(SJF5003), lysA::pmecA rpoC-G740R (SJF5034) and genetically complemented lysA::pmecA
rpoB+ (SJF5044) and lysA::pmecA rpoC+ (SJF5045) as well as COL and COL rpoB+ (SJF5049)
strains.
(PDF)
S2 Fig. Nucleotide addition and pyrophosphorolysis by SH1000, lysA::pmecA rpoB-H929Q
and lysA::pmecA rpoC-G740R RNAPs. A) RNA was radiolabelled on the 3’ end to produce
an RNA of 14 nt. Nucleotide addition resulted in the production of an RNA product of 15 nt.
(I) Schematic of scaffold before and after nucleotide addition. (II) 23% w/v polyacrylamide
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denaturing gel showing nucleotide addition over time. Observed rate constants (Kobs) are
shown below the gel (numbers that follow the ± sign are standard errors). B) RNA of was
radiolabelled on the 5’ end to produce an RNA of 13 nt. Pyrophosphorolysis first resulted in
the production of an RNA product of 14 nt, subsequent pyrophosphorolysis produced shorter
products. (I) Schematic of scaffold before and after pyrophosphorolysis. (II) 23% w/v poly-
acrylamide denaturing gel showing pyrophosphorolysis over time. Observed rate constants
(Kobs) are shown below the gel (numbers that follow the ± sign are standard errors).
(PDF)
S3 Fig. Transcription elongation and pausing of SH1000, lysA::pmecA rpoB-H929Q and
lysA::pmecA rpoC-G740R RNAPs. The assembled scaffold was used to examine differences in
pausing by three RNAPs during elongation. The trace of each reaction at 30 seconds on the
23% w/v polyacrylamide denaturing gels can be seen.
(PDF)
S4 Fig. Misincorporation by SH1000, lysA::pmecA rpoB-H929Q and lysA::pmecA rpoC-
G740R. RNA of was radiolabelled on the 5’ end to produce an RNA of 13 nt. Misincorporation
resulted in the production of an RNA product of 15 nt. A) Schematic of scaffold before and
after misincorporation. B) 23% w/v polyacrylamide denaturing gel showing misincorporation
over time. Observed rate constants (Kobs) are shown below the gel (numbers that follow
the ± sign represents standard errors).
(PDF)
S5 Fig. RNA hydrolysis of a non-cognate nucleotide by SH1000, lysA::pmecA rpoB-H929Q
and lysA::pmecA rpoC-G740R. RNA was radiolabelled on the 5’ end to produce an RNA of 15
nt. Hydrolysis resulted in the production of a radiolabelled RNA product of 13 nt. A) Intrinsic
cleavage of mis-incorporated nucleotide by RNAPs; (I) Schematic of scaffold before and after
intrinsic hydrolysis. (II) 23% w/v polyacrylamide denaturing gel showing hydrolysis over time.
Observed rate constants (Kobs) are shown below the gel (numbers that follow the ± sign are
standard errors). B) Gre factor-associated hydrolysis of mismatched nucleotide by RNAPs.
Gre-assisted hydrolysis resulted in the production of a radiolabelled RNA product of 13 nt. (I)
Schematic of scaffold before and after hydrolysis. (II) 23% w/v polyacrylamide denaturing gel
showing hydrolysis over time. Observed rate constants (Kobs) are shown below the gel (num-
bers that follow the ± sign are standard errors).
(PDF)
S6 Fig. Transcription of SH1000, lysA::pmecA rpoB-H929Q and lysA::pmecA rpoC-G740R
on T7A1 in the presence and absence of oxacillin at high and low concentrations. The ter-
minator (Term), run off (R/O) and abortive products produced after 30 min of T7A1 incuba-
tion with the RNAPs were visualised on a 20% w/v polyacrylamide denaturing gel.
(PDF)
S7 Fig. Schematic representation of high-level MRSA selection using multicopy plasmid-
borne mecA and subsequent strain evolution. A) Schematic representation of antibiotic gra-
dient plate of two layers. Bottom layer consists of plain BHI agar, top layer supplemented with
5/20 μg/ml methicillin. B) Resistance properties of pRB474-pmecA (SJF4981) and its parental
MSSA, SH1000 strain. C) Use of a gradient plate to select for high-level oxacillin resistance. D)
The Etest strips revealed high-level oxacillin resistance which required presence of the
pRB474-pmecA.
(PDF)
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S8 Fig. Schematic of the GdpP operon, showing the acquired SNPs and effect of gdpP dele-
tion on resistance. A) The genomic region of the gdpP operon along with rplI and dnaC
genes. The N-terminus of the GdpP protein contains two transmembrane helices (black
boxes), a PAS domain, GGDEF, DHH and DHHA1 domains. Amino acid substitutions identi-
fied in highly resistant derivatives of pRB474-pmecA (SJF4981) are indicated and strain details
are shown in boxes. B) The inactivation of gdpP in ΔgdpP::kanR (SJF5025) showed susceptibil-
ity to oxacillin in the absence of mecA. Subsequent introduction of pRB474-pmecA into
ΔgdpP::kanR (SJF5025) resulted in ΔgdpP::KanR pRB474-pmecA (SJF5026) was accompanied
by high-level resistance to oxacillin. The MIC for oxacillin determined by Etest is listed in
brackets.
(PDF)
S9 Fig. Reintroduction of mecA into pmecA cured backgrounds. A) gdpP-R318L (SJF4993)
was transduced with single copy mecA using RN4220 lysA::pmecA (SJF4994) as a donor strain
for the chromosomal integration of pmecA into the multicopy mecA (pRB474-pmecA) cured
background. B) Vice versa, lysA::kan rpoB-H929Q (SJF5010) was introduced with multicopy
plasmid-borne pRB474-pmecA into the single copy mecA cured background. Oxacillin MICs
are listed in brackets for all strains.
(PDF)
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